Radio pharmaceticals and supplies
Ended Awarded Last action
- Contract number
- W81K0024F0149
- Awardee
-
Cardinal Health 414, LLC UEI CWN9UGL3NCL9 Part of Cardinal Health, Inc.
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $250,000
Award facts
- Contract value 100% obligated
- $249,999.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Fort Bliss, TX 79916, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Funding Only Action | $250,000 | |
| Original award | $0 |
About this award
The Defense Health Agency awarded Cardinal Health 414, LLC a Blanket Purchase Agreement (BPA) call for radiopharmaceuticals and supplies valued at $249,999.99 under a firm fixed-price contract structure. This award, issued October 1, 2024, with an ultimate completion date of September 30, 2025, carries no set-aside designation and represents a call against Cardinal Health 414's existing BPA with the Defense Health Agency. Cardinal Health 414, a subsidiary of Cardinal Health, Inc. headquartered in Dublin, Ohio, specializes in the manufacturing, testing, and distribution of radiopharmaceuticals and medical isotopes critical to nuclear medicine and diagnostic imaging services. The contract will be performed at Fort Bliss, Texas, supporting the Defense Health Agency's medical supply requirements for military treatment facilities.
Cardinal Health 414 maintains an established role as a critical supplier of time-sensitive radiopharmaceutical products to federal healthcare agencies, including the Department of Veterans Affairs and Department of Defense. The company's radiopharmaceutical portfolio encompasses products such as technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, and specialized therapeutics including Xofigo for prostate cancer treatment and Lymphoseek for diagnostic imaging. The company's federal contracting activity demonstrates extensive experience with Indefinite Delivery Vehicle contracts across multiple Veterans Integrated Service Networks and substantial BPA relationships with the Defense Health Agency, positioning it as an established single-source supplier for proprietary radiopharmaceutical products essential to the federal healthcare system.
Quick answers
Who was awarded contract W81K0024F0149?
W81K0024F0149 was awarded to Cardinal Health 414, LLC by Medical Command (Department of the Army) on October 1, 2024.
How much is contract W81K0024F0149 worth?
The government has obligated $250,000 on W81K0024F0149.
Which agency awarded contract W81K0024F0149?
Medical Command (Department of the Army) awarded W81K0024F0149, with funding from Defense Health Agency (Department of Defense).
Is contract W81K0024F0149 an order under another contract?
Yes. W81K0024F0149 is a BPA call under W81K0020A0009, a blanket purchase agreement.
Was contract W81K0024F0149 competed?
The extent of competition for W81K0024F0149 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award